ArticleFrontiers in public health2025
Antimicrobial resistance in the Eastern Mediterranean Region: experiences, challenges, and perspectives.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- A Systematic Review of β-Lactamase and Carbapenemase-ProducingVeterinary sciences · 2026Review
- Antibiotic Resistance Genes in Salmonella Isolates from Food Production Environments and Clinical Sources in the Middle East: A Systematic Review and Meta-Analysis Revealing the Limited Comparative Genomic Evidence.Life (Basel, Switzerland) · 2026Review
- Antimicrobial resistance in poultry meat in the mediterranean region: prevalence, public health implications, and control strategies: A review.Poultry science · 2026Review
- Burden of Bacterial Antimicrobial Resistance in Libya, 1970-2024: A Systematic Meta-Analysis with Projections to 2050.Antibiotics (Basel, Switzerland) · 2026Review
- Antimicrobial-Resistant Infections in the Eastern Mediterranean Region (EMR): Burden, Mortality Trends, and Progress Toward AMR Reduction Milestones (2013-2023).Health services insights · 2026Article
- Antimicrobial resistance patterns in a Qatari tertiary care center in 2024: A retrospective study.Qatar medical journal · 2026Article
- From burden to action: Saudi Arabia's strategy on antimicrobial resistance.Open medicine (Warsaw, Poland) · 2026Review
- Forty Years of Primary Health Care (PHC) in Iran: Achievements, Lessons and Future Directions.Medical journal of the Islamic Republic of Iran · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) is a rapidly growing global health threat that undermines the effectiveness of first-line treatments for serious infectious diseases. During the Eighth Regional Conference of the Eastern Mediterranean Public Health Network (EMPHNET), held in Amman, Jordan, from September 15-18, 2024, this critical issue took center stage under the theme "Advancing Public Health Preparedness and Response." A dedicated roundtable discussion on AMR explored the challenges of implementing effective AMR surveillance, the widespread misuse of antibiotics, and the urgent need for a One Health approach that integrates human, animal, and environmental health. Speakers emphasized that political commitment, sustainable funding, and cross-sector collaboration are essential to curbing AMR, particularly in the Eastern Mediterranean Region (EMR), where factors such as high antimicrobial consumption, conflict, weak health systems, and poor access to regulated antibiotics exacerbate the problem. The discussion also highlighted the critical roles of laboratories and infection prevention and control (IPC) programs in healthcare settings, both of which are central to AMR surveillance and stewardship. Global efforts, including the WHO's Global Action Plan on AMR and the AMR Multi-Stakeholder Partnership Platform, were recognized as vital frameworks for fostering international cooperation and guiding regional responses. The roundtable concluded with a call for strengthened governance, enhanced laboratory capacities, improved surveillance systems, scaling up IPC programs and enhanced public awareness campaigns to confront the rising threat of AMR in the EMR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.